Reuters logo
BRIEF-Vistagen Therapeutics posts Q2 loss of $0.53 per share
2017年11月9日 / 晚上9点38分 / 12 天前

BRIEF-Vistagen Therapeutics posts Q2 loss of $0.53 per share

Nov 9 (Reuters) - Vistagen Therapeutics Inc

* Vistagen therapeutics reports second fiscal quarter 2018 financial results and provides business update

* Qtrly ‍basic and diluted net loss attributable to common stockholders per common share​ of $0.53 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below